Ryugasaki, Japan

Masanao Matsuo



 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Naka-gun, JP (2010)
  • Ryugasaki, JP (2015 - 2016)

Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Masanao Matsuo

Introduction

Masanao Matsuo is a notable inventor based in Ryugasaki, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the quantification of biomarkers related to malignant tumors. With a total of three patents to his name, Matsuo's work has the potential to impact clinical practices and improve patient outcomes.

Latest Patents

One of Matsuo's latest patents is a method for quantifying soluble LR11 in biological samples, such as serum. This method allows for convenient and accurate immunological quantification without the need for complicated separation manipulations. Another significant patent is a method for diagnosing malignant tumors. This method includes a diagnostic kit for determining the presence and severity of malignant tumors, as well as evaluating therapeutic methods and estimating the risk of recurrence.

Career Highlights

Throughout his career, Matsuo has worked with prominent companies in the medical field, including Sekisui Medical Co., Ltd. and Daiichi Pure Chemicals Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative diagnostic methods.

Collaborations

Matsuo has collaborated with notable colleagues, including Hiroyuki Ebinuma and Isamu Fukamachi. These collaborations have likely enhanced his research and development efforts in the medical diagnostics arena.

Conclusion

Masanao Matsuo's contributions to medical diagnostics through his innovative patents demonstrate his commitment to advancing healthcare technology. His work has the potential to significantly improve the accuracy of tumor diagnosis and patient management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…